In this study, we found that plasma S1P levels were significantly lower and plasma MonCer and LacCer levels were significantly higher in all neurodegenerative disease groups (IPD, DLB, MSA, AD, and PSP) than in the CN group by plasma lipidomics. The gene discussed is MBTPS1; the disease is supranuclear palsy, progressive, 1.